Literature DB >> 15674353

Treatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovir.

M Luppi, R Trovato, P Barozzi, D Vallisa, G Rossi, A Re, L Ravazzini, L Potenza, G Riva, M Morselli, G Longo, L Cavanna, R Roncaglia, G Torelli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15674353     DOI： 10.1038/sj.leu.2403646

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  24 in total

Review 1.  Current status of treatment for primary effusion lymphoma.

Authors:  Seiji Okada; Hiroki Goto; Mihoko Yotsumoto
Journal:  Intractable Rare Dis Res       Date:  2014-08

Review 2.  Current and potential treatments for ubiquitous but neglected herpesvirus infections.

Authors:  Jonathan E Gable; Timothy M Acker; Charles S Craik
Journal:  Chem Rev       Date:  2014-10-02       Impact factor: 60.622

3.  Sustained complete remission of primary effusion lymphoma with adjunctive ganciclovir treatment in an HIV-positive patient.

Authors:  Rui Pereira; Joana Carvalho; Catarina Patrício; Pedro Farinha
Journal:  BMJ Case Rep       Date:  2014-10-13

Review 4.  Use of cidofovir for the treatment of HIV-negative human herpes virus-8-associated primary effusion lymphoma.

Authors:  Tamara K Moyo; Kristy L Richards; Blossom Damania
Journal:  Clin Adv Hematol Oncol       Date:  2010-05

5.  Antineoplastic effects of liposomal short interfering RNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma.

Authors:  Giovanni Riva; Ivana Lagreca; Adriana Mattiolo; Daniela Belletti; Laura Lignitto; Patrizia Barozzi; Barbara Ruozi; Daniela Vallerini; Chiara Quadrelli; Giorgia Corradini; Fabio Forghieri; Roberto Marasca; Franco Narni; Giovanni Tosi; Flavio Forni; Maria Angela Vandelli; Alberto Amadori; Luigi Chieco-Bianchi; Leonardo Potenza; Maria Luisa Calabrò; Mario Luppi
Journal:  Haematologica       Date:  2015-07-23       Impact factor: 9.941

6.  Concurrent targeting of eicosanoid receptor 1/eicosanoid receptor 4 receptors and COX-2 induces synergistic apoptosis in Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus associated non-Hodgkin lymphoma cell lines.

Authors:  Arun George Paul; Bala Chandran; Neelam Sharma-Walia
Journal:  Transl Res       Date:  2013-03-20       Impact factor: 7.012

7.  STAT3 Regulates Lytic Activation of Kaposi's Sarcoma-Associated Herpesvirus.

Authors:  Christine A King; Xiaofan Li; Arturo Barbachano-Guerrero; Sumita Bhaduri-McIntosh
Journal:  J Virol       Date:  2015-09-02       Impact factor: 5.103

Review 8.  New approaches to the treatment of human herpesvirus 8-associated disease.

Authors:  Corey Casper
Journal:  Rev Med Virol       Date:  2008 Sep-Oct       Impact factor: 6.989

9.  Primary effusion lymphoma diagnosed by pericardiocentesis.

Authors:  Michael C Nemunaitis; Jeffrey M Schussler; S Michelle Shiller; Louis M Sloan; Robert G Mennel
Journal:  Proc (Bayl Univ Med Cent)       Date:  2009-01

10.  An unusual case of Primary Effusion Lymphoma with aberrant T-cell phenotype in a HIV-negative, HBV-positive, cirrhotic patient, and review of the literature.

Authors:  Charitini Nepka; Dimitrios Kanakis; Maria Samara; Andreas Kapsoritakis; Spyridon Potamianos; Maria Karantana; Georgios Koukoulis
Journal:  Cytojournal       Date:  2012-06-29       Impact factor: 2.091
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.